Drug Eluting Coronary Artery Stents

Publisher： Bentham Science Publishers

E-ISSN： 1875-5704|7|5|421-427

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.7, Iss.5, 2010-12, pp. : 421-427

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Percutaneous coronary intervention with drug-eluting stents or coronary artery bypass surgery in subjects with type 2 diabetes

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 9, 2013-06 ,pp. : 1269-1273

Informa Healthcare

Access to resources Recommend Favorite

Sirolimus- or paclitaxel-eluting stents for coronary artery revascularisation

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 2, 2006-02 ,pp. : 225-228

Informa Healthcare

Access to resources Recommend Favorite

Sirolimus: Coronary artery aneurysms following implantation of drug-eluting stents in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1181, 2007-01 ,pp. : 34-35

Adis International

Access to resources Recommend Favorite

Sirolimus- or paclitaxel-eluting stents to prevent coronary artery restenosis

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 11, 2004-11 ,pp. : 2209-2220

Informa Healthcare

Access to resources Recommend Favorite

Sirolimus- versus paclitaxel-eluting stents in patients with stenosis in a native coronary artery

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 6, 2004-06 ,pp. : 1431-1434

Informa Healthcare

Access to resources Recommend Favorite